entertainment -WSS

entertainment

author：leisure time 2025-09-28 02:32:38 - browse：3

Adobe

You didn’t need machine learning to make one prediction about the year’s biggest conference for health care investors, which was held in San Francisco last week. It was going to rain.

Recursion, a biotechnology firm that uses machine learning for drug development and that was announcing that it is rolling out AI-driven drug discovery software with tech giant Nvidia, decided to seize the moment. As the heavens opened, Recursion employees handed out black umbrellas emblazoned with the Recursion logo and lined with neon images of cells. It was one of a series of publicity grabs from the company, including a satellite event featuring Nvidia’s famous CEO, Jensen Huang, who has become a Wall Street rock star as his company’s stock has exploded due to rising expectations for AI, reaching a $1 trillion market value, the sixth highest in the world.

Seeing the square outside the Westin St. Francis, where the J.P. Morgan Healthcare Conference has been held for 42 years, fill with Recursion’s umbrellas was a little like seeing the message that AI was ready for its debut come to life. But it was also true that not everyone was ready to embrace that message.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： PEPFAR is under serious threat — and so is global health

WSS

Acelyrin, a rare IPO success, stumbles in its first big test

New weight loss drugs vying to be the next Wegovy or Mounjaro

Food makers tried to stack nutrition panel with preferred experts

With psoriasis trial ahead, Alumis raises $259 million

How medical schools plan to diversify without affirmative action

A common UTI test for kids haunts adults as a traumatic 'nightmare'

hotspot

entertainment

focus

Peter Hotez and the public health issue of online harassment

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Tori Bowie and the unacceptable rates of Black maternal death

Hospitals consider fixing cancer drug shortages on their own

Tori Bowie and the unacceptable rates of Black maternal death

Food makers tried to stack nutrition panel with preferred experts

Malaria cases in Florida and Texas: Here’s what you need to know

FDA proposes changes to key medical devices approval pathway

Virginia high school admissions case could be legal follow

Change Healthcare cyberattack prompts Medicare loan program

focus

White House touts steps to stem shortages of cancer treatments

Just how do doctors, lawmakers, and the public define abortion?

Amylyx ALS drug failure raises questions and concerns

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

The problem with charging patients to message their doctors

FDA panel endorses Alnylam’s heart drug — after picking it apart

knowledge

focus

Wikipedia

explore